Effect of antinuclear antibodies on pharmacokinetics of anti-TNF therapy in patients with inflammatory bowel disease.

Eirini TheodorakiEleni OrfanoudakiKalliopi FoteinogiannopoulouNikolaos-Panagiotis AndreouMaria GazouliIoannis E Koutroubakis

Published in: International journal of colorectal disease (2022)

In IBD patients under maintenance therapy with anti-TNF ANA positivity is associated with lower TLs. The clinical significance of this finding remains to be defined in future larger prospective studies.

Keyphrases

patients with inflammatory bowel disease
end stage renal disease
rheumatoid arthritis
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
current status
cell therapy
patient reported
case control